Women’s Empowerment Cancer Advocacy Network (WE CAN) Conference Global Efforts to Address the Rising Cancer Burden Dar es Salaam, Tanzania, September 2014.

Slides:



Advertisements
Similar presentations
Eduardo Cazap, President Global projects under the auspices of UICC.
Advertisements

Global Measles and Rubella Strategic Plan
The Global Burden of Hepatitis C Dr Daniel Lavanchy World Health Organization (WHO) Geneva, Switzerland 3 rd Paris Hepatitis Conference.
Maternal, neonatal, child health and nutrition
Introduction to Treat the Pain. The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain.
NCI Center for Global Health Jo Anne Zujewski, M.D. September 11, 2014 Dar es Salaam, Tanzania.
Non Communicable Disease
Technical Advisory Group meeting, WHO/WPRO
European Forum for Primary Care: "Twinning Population Health and Primary Care" Barcelona, Spain, 1-2 September, 2014 WHO Strategy on People-Centered and.
The Work of WHO in the South-East Asia Region The Work of WHO in the South-East Asia Region Biennial Report of the Regional Director 1 January
Breast Cancer in Eastern Europe and Central Asia Julie R. Gralow, M.D. Professor and Director, Breast Medical Oncology University of Washington School.
Marrakech, Morocco, June 2010 Contents Global burden of cancer Recommendations Regional challenges in cancer prevention and control Regional burden.
BREAST CANCER EPIDEMIOLOGY AND BREAST PHYSIOLOGY Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.
Radiation Oncology: A Global Perspective Compiled by the Global Health Initiative Subcommittee (ARRO) Please refer to the sources listed below each chart/graph/table.
Non-communicable diseases David Redfern
Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment National Cancer Institute January
THE FIGHT TO STOP TB WHAT ARE WE FIGHTING? TUBERCULOSIS: THE WORLD’S NO. 1 KILLER AMONG CURABLE, INFECTIOUS DISEASES But there is hope PEOPLE WHO HAVE.
ADAMOS ADAMOU, MEDICAL ONCOLOGIST MEMBER OF THE EUROPEAN PARLIAMENT.
Challenges of Global Alcohol Policy Developments FIVS Public Policy Conference 7-9 April 2014 Brussels, Belgium.
11 Bill & Melinda Gates Foundation Global Libraries Initiative April 2007.
THANK YOU!. Regional Adviser, Noncommunicable Diseases, WHO/EMRO Dr Ibtihal Fadhil.
National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP)  Vision: a nation in which all people live healthy lives free from the devastation.
Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.
Health Care Reform Through the Cancer Lens State and Private Sector Reforms for Hispanic Healthcare Edward E. Partridge, MD National Board President American.
WHO Technical Briefing Seminar on Essential Medicines & Health Products, October 2013 Noncommunicable Diseases –Action Plan Dr Shanthi Mendis Director,
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
Dr Godfrey Xuereb Team Leader Surveillance and Population-based Prevention Department for the Prevention of NCDs A comprehensive global monitoring framework.
BREAST HEALTH GLOBAL INITIATIVE(BHGI) SUPPORTIVE CARE GUIDELINES& THEIR ROLE IN ADVOCACY : The Uganda Experience Gertrude Nakigudde Patient Advocate Uganda.
World Health Organization Department of Chronic Diseases and Health Promotion World Health Organization Global Perspective on Health Promotion Tang Kwok-cho.
Surveillance Systems: Their Role in Identifying Risk and Resilience Factors Diego E Zavala, M.Sc., Ph.D. Associate Professor Public Health Program, Ponce.
HPV VACCINATION Dr Frida Mghamba 2 nd East Africa WE CAN Summit 11 th September 2014.
Ibero-American Road Safety Conference Madrid, February 23-24, World Bank Global Road Safety Facility.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
The Rising Prevalence of NCDs: Implications for Health Financing and Policy Charles Holmes, MD, MPH Office of the U.S. Global AIDS Coordinator Department.
What is ADI Alzheimer’s Disease International, the worldwide federation of 76 national Alzheimer associations Each member is the leading association in.
Promoting patient-centred healthcare around the world Stephen McMahon IAPO Governing Board Member Adult Immunization: A Central Driver of Prevention and.
Millennium Development Goals Rachel Reyes. Goal one – Eradicate extreme hunger and poverty. The goals of the government to achieve this is to: Halve the.
National Perspective Cancer Early Detection & Prevention Performance Review Event October 2008 National Cancer Action Team Kathy Elliott National Lead.
Monitoring UA 2010 in health sector 1 |1 | Monitoring progress towards Universal Access 2010 in the health sector Kevin M De Cock Ties Boerma.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
Global Alliance against Chronic Respiratory Diseases GARD/NCD Action Plan & 2011 UN Summit on NCDs Niels H. Chavannes MD PhD Associate.
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
The Millennium Development Goals The fight against global poverty and inequality.
HIV/AIDS A MAJOR DEVELOPMENT CONCERN FOR THE AFRICAN DEVELOPMENT BANK March 2008.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
Call to action on NCDs: Challenges and Way Forward for Maternal and Child Health Dr. Niloufer Sultan Ali Professor, Family Medicine Aga Khan University,
Position on HPV vaccinesAvailable from In July 2013, The Global Advisory Committee on Vaccine Safety (GACVS) of the WHO reconfirmed that there had been.
Feedback by NGOs to the NCD Alliance on the WHO Discussion Paper on a comprehensive global monitoring framework and voluntary global targets for prevention.
Cervical Cancer How We Can Prevent It Dr Quek Swee Chong Himalayan Women’s Health Project 30 August 2014.
World Health Day Objectives Increase awareness about the rise in diabetes, and its staggering burden and consequences, in particular in low- and.
An Overview of the Burden of Non- Communicable Diseases (NCDs) Dr Sylvia J Anie Director Social Transformation Programmes Division (Education, Health,
World Health Organization Non-communicable disease prevention and control: key messages 1.Non-communicable diseases are a major public health and socio-
#AIDS2016 Cervical Cancer Prevention in Africa: The Future Nelly Yatich, DrPH University of California San Francisco July 19 th, 2016.
The Global Cancer Agenda and the Role of Patient Advocacy Julie R. Gralow, M.D. Director, Breast Medical Oncology Jill Bennett Endowed Professor of Breast.
Nick Banatvala & Pascal Bovet
Supportive Care During and After Treatment
THENG Youdaline KRUY Leang Sim
19/05/2018 Acción Global para el Control de Cáncer Infantil Dr Oleg Chestnov Asistente Director-General Enfermedades No Comunicables y Salud Mental Organizacion.
World Health Organization
World Health Organization
Global and national approaches to reducing the harmful use of alcohol
How does teamwork improve value. Dr Nils E
GARD/NCD Action Plan & 2011 UN Summit on NCDs
World Health Organization
Progress and Challenges with achieving Universal Immunization Coverage
Pharmacists Optimizing Cancer Care
Millennium Development Goals (MDGs)
528,000 new cases 266,000 death 90 % of the deaths in LMIC
Dr Timothy Armstrong Coordinator
Presentation transcript:

Women’s Empowerment Cancer Advocacy Network (WE CAN) Conference Global Efforts to Address the Rising Cancer Burden Dar es Salaam, Tanzania, September 2014 Julie R. Gralow, M.D. Jill Bennett Endowed Professor of Breast Cancer Director, Breast Medical Oncology Professor, Global Health University of Washington School of Medicine Fred Hutchinson Cancer Research Center Seattle Cancer Care Alliance

MYTH Cancer is a disease of developed countries FACT Low and middle-income countries now bear a majority share of the burden of cancer

Globocan 2008 Cancer Incidence and Deaths Less Developed versus More Developed Countries Cancer Incidence Cancer Deaths Less Developed More Developed Less Developed 4.8 million; 64% 2.7 million; 37% 7.1 million; 56% 5.6 million; 44%

Percent of Worldwide Cancers Diagnosed in Developing Countries 1970 – 15%1970 – 15% 2008 – 56%2008 – 56% 2030 – 70%2030 – 70% Ferlay J, et al. GLOBOCAN Lyon: International Agency for Research on Cancer, 2010Ferlay J, et al. GLOBOCAN Lyon: International Agency for Research on Cancer, 2010 Beaulieu N, et al. Breakaway: the global burden of cancer—challenges and opportunities. A report from the Economist Intelligence Unit, 2009.Beaulieu N, et al. Breakaway: the global burden of cancer—challenges and opportunities. A report from the Economist Intelligence Unit, 2009.

Most Common Cancer Site in Females Globally Source: GLOBOCAN 2008

Source: Knaul, Arreola, Mendez. estimates based on IHME, The Cancer Transition in Low and Middle Income Countries (LMICs): Breast and Cervical Cancer 53% 20% 19% -31% 0% LMIC’s High income % Change in # of deaths LMICs account for >90% of cervical cancer deaths and >60% of breast cancer deaths. Both diseases are leading killers – especially of young women.

Cancer Estimates for Africa Ferlay et. al :2008: –681,000 diagnosed –512,400 deaths 2030 (projected):2030 (projected): –1.28 million diagnosed –970,000 deaths

Cancer Care and Control: A Call to Action Farmer P et al, Lancet, August 2010

Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries Task Force report available as free pdf download: Force report available as free pdf download:

Global Task Force Report: Core Elements of a Cancer Care and Control Strategy Many cancers are preventable through infection control and lifestyle modificationsMany cancers are preventable through infection control and lifestyle modifications Accurate cancer diagnosis is critical to determining an appropriate and successful treatment planAccurate cancer diagnosis is critical to determining an appropriate and successful treatment plan Many cancers are highly treatable with affordable therapies that result in the addition of many years of lifeMany cancers are highly treatable with affordable therapies that result in the addition of many years of life –Denial of therapy for diseases that are highly curable with affordable drugs is unacceptable Palliation of pain and suffering from cancer is a basic human rightPalliation of pain and suffering from cancer is a basic human right Reliable data is needed to understand the magnitude of the cancer burden and the potential impact of interventionsReliable data is needed to understand the magnitude of the cancer burden and the potential impact of interventions

A Global Call to Action UN High-level Meeting on Prevention & Control of Non-Communicable Diseases (NCDs) September 19-20, 2011 Millennium Development Goals expire 2015Millennium Development Goals expire 2015 NCDs – cancer, cardiac, respiratory, diabetes – a major challenge to health and development in 21st centuryNCDs – cancer, cardiac, respiratory, diabetes – a major challenge to health and development in 21st century NCDs a priority for UNNCDs a priority for UN Goal of 25% reduction in preventable deaths due to NCDs by 2025Goal of 25% reduction in preventable deaths due to NCDs by 2025

WHO Global Monitoring Framework for NCDs Provides a clear vision for action by 2025Provides a clear vision for action by 2025 UN Member States formally adopted the global monitoring framework as part of a comprehensive "Omnibus" Resolution at the 66th World Health Assembly in May 2013UN Member States formally adopted the global monitoring framework as part of a comprehensive "Omnibus" Resolution at the 66th World Health Assembly in May 2013 –9 global targets –25 indicators Primary Target:

Global NCD Targets for 2025

WHO Global Monitoring Framework for NCDs: Selected Cancer-related Metrics 80% availability of affordable basic technologies & essential medicines required to treat major NCDs80% availability of affordable basic technologies & essential medicines required to treat major NCDs Access to palliative care assessed by morphine equivalent consumption of strong opioid analgesics per death from cancerAccess to palliative care assessed by morphine equivalent consumption of strong opioid analgesics per death from cancer Availability, if cost ‐ effective and affordable, of vaccines against human papillomavirus (HPV)Availability, if cost ‐ effective and affordable, of vaccines against human papillomavirus (HPV) Vaccination coverage against HBV monitored by number of 3rd doses of Hep ‐ B vaccine administeredVaccination coverage against HBV monitored by number of 3rd doses of Hep ‐ B vaccine administered Proportion of women between screened for cervical cancer at least onceProportion of women between screened for cervical cancer at least once

Global Alliance for Vaccines and Immunization (GAVI) and HPV Vaccine Pricing Effective May 2013, lowest income countries have access to HPV vaccines for US $4.50 per doseEffective May 2013, lowest income countries have access to HPV vaccines for US $4.50 per dose –Same vaccines costs > $100 in developed countries –Previous lowest public sector price $13 per dose GAVI working mostly in Africa, preparing for introducing the HPV vaccine through national roll out or pilot projectsGAVI working mostly in Africa, preparing for introducing the HPV vaccine through national roll out or pilot projects –Anticipated that > 30 million girls will be immunized by 2020

UN High-level Meeting - Comprehensive Review and Assessment of the Progress Achieved in the Prevention and Control of Non-Communicable Diseases (NCDs) July 10-11, 2014 WHO report: NCDs country profiles 2014WHO report: NCDs country profiles 2014http://

US NCI Center for Global Health Established November, Goals:Goals: –Advance global cancer research, build expertise and leverage resources across nations to address challenges of cancer and reduce cancer deaths worldwide –Advance global cancer research, build expertise and leverage resources across nations to address challenges of cancer and reduce cancer deaths worldwide

American Society of Clinical Oncology (ASCO) International Portfolio of education and research opportunities to accelerate collaboration between members, organizations, and countriesPortfolio of education and research opportunities to accelerate collaboration between members, organizations, and countries –Multidisciplinary Cancer Management Courses –International Clinical Trials Workshops –Palliative Care Courses –Oncology for the Non-Oncologist Course –International Development and Education Awards (IDEA) –International Innovation Grants

2007 Institute of Medicine Report Cancer Control Opportunities in Low- and Middle-Income Countries Sloan FA, et al, National Academies Press, 2007 Patient advocacy has a key role to play in bringing the public’s concerns about cancer to decision makersPatient advocacy has a key role to play in bringing the public’s concerns about cancer to decision makers Summary recommendations: AdvocacySummary recommendations: Advocacy –Provide active support and assistance of cancer advocacy in low- and middle-resource countries –Suggested activities: »Set up advocacy networks within countries, regions, internationally »Identify successful approaches to cancer advocacy and replicate/adapt for use in other settings »Provide hands-on training and technical assistance

Promotion of public advocacy for breast and cervical cancer Women’s Empowerment Cancer Advocacy Network (WE CAN) Goals: To combat breast and cervical cancer by building and supporting advocacy groups with skills to address:To combat breast and cervical cancer by building and supporting advocacy groups with skills to address: –inadequacy in information –inequity in treatment and care –injustice in breast nd cervical cancer early detection, screening, treatment, and prevention

WE CAN Eastern Europe/Central Asia Breast and Cervical Cancer Advocacy Conferences Vilnius, Lithuania 2003 Kiev, Ukraine 2005 Minsk, Belarus 2007 Bishkek, Kyrgyzstan 2009 Vilnius, Lithuania 2011 Tbilisi, Georgia 2013

WE CAN East Africa Breast and Cervical Cancer Advocacy Conferences Kampala, Uganda September 2013 Dar es Salaam, Tanzania October 2014

The Power of Social Media: Connecting Across Continents #WECAN14 Twitter chat tonight 6-7 pm with breast cancer patient advocates in North America!#WECAN14 Twitter chat tonight 6-7 pm with breast cancer patient advocates in North America!

MYTH It’s too expensive and there are too many obstacles to prevent or treat cancer in developing countries FACT Much can be done to prevent, treat and palliate cancer even in resource-constrained settings

The time has come to challenge and disprove the assumption that cancer cannot be prevented, treated, or palliated in developing countries